News from the web:
In the wake of research suggesting a skin-cancer drug may have benefits in treating Alzheimer’s disease, physicians and advocacy groups are getting a flurry of calls from patients seeking to use the drug off-label.
The clamor underscores how urgently patients want solutions to the rising tide of Alzheimer’s. But experts caution that more research is needed to determine whether the drug, bexarotene, is effective in humans at all, not to mention what the dosage should be.
The study, published Thursday in the journal Science, was conducted in mice, and the road to an effective Alzheimer’s treatment is littered with failures that looked promising early on in animals.
Read all about it HERE